DxBooks
Overview
Three high-quality datasets to suit your needs
The DxBooks cover U.S. labs’ testing behaviors in the areas of oncology biomarkers, infectious disease diagnostics, and SARS-CoV-2 testing.
Each database offers detailed quantitative and qualitative information about labs’ test adoption, kits and platforms used, volumes, trends, and more.
Historical data going back up to five years offers further opportunity to track changes in the relevant markets over time.
Intuitive browser-accessible Tableau interfaces complement delivery of the raw data to facilitate point-and-click custom data slicing and quick insights.
NGS DxBook
The NGS Oncology DxBook, piloted in 2022 and revamped in 2023, captures in-depth information regarding in-house and send-out oncology NGS panel testing behaviors.

Infectious Disease DxBook
The Infectious Disease DxBook captures molecular diagnostics testing information for 31 targets, including volumes, technologies, and trends, as well as counts of in-use instruments by manufacturer.
%25203.png)
Oncology DxBook
Oncology Biomarker testing information captured from ~300 hospital and reference labs annually throughout the U.S.
